Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated : 05/19/2022

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Allogeneic hematopoietic stem cell transplantation for heavily pretreated patients with mycosis fungoides and Sezary syndrome.

Condition: Mycosis Fungoides and Sezary Syndrome
Journal: Dermatologic therapy
Treatment Used: Allogeneic Hematopoietic Stem Cell Transplantation
Number of Patients: 19
Published: March 15, 2022
View publication
Summary: Allogeneic hematopoietic stem cell transplantation for heavily pretreated patients with mycosis fungoides and Sezary syndrome.

What factors guide treatment selection in mycosis fungoides and Sezary syndrome?

Journal: Hematology. American Society of Hematology. Education Program
Published: December 10, 2021
View publication
Summary: What factors guide treatment selection in mycosis fungoides and Sezary syndrome?

Patterns of Care and Outcomes by Treatment Era in Mycosis Fungoides.

Condition: Mycosis Fungoides (MF) and Sezary Syndrome (SS)
Journal: International journal of radiation oncology, biology, physics
Treatment Used: Chemotherapy (CMT), Radiotherapy (RT), and Immunotherapy
Number of Patients: 9462
Published: October 27, 2021
View publication
Summary: Patterns of Care and Outcomes by Treatment Era in Mycosis Fungoides.

Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study.

Condition: Relapsed or Refractory Mycosis Fungoides or Sézary syndrome
Journal: The Lancet. Haematology
Treatment Used: Intralesional TTI-621
Number of Patients: 66
Published: October 10, 2021
View publication
Summary: Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study.

Spectrum of mutational signatures in T-cell lymphoma reveals a key role for UV radiation in cutaneous T-cell lymphoma.

Journal: Scientific reports
Published: February 18, 2021
View publication
Summary: Spectrum of mutational signatures in T-cell lymphoma reveals a key role for UV radiation in cutaneous T-cell lymphoma.

Mycosis Fungoides and Sézary Syndrome: Updates and Review of Current Therapy.

Condition: Mycosis Fungoides and Sézary Syndrome
Journal: Current treatment options in oncology
Treatment Used: Allogeneic Hematopoietic Stem Cell Transplantation
Number of Patients: NULL
Published: January 08, 2021
View publication
Summary: Mycosis Fungoides and Sézary Syndrome: Updates and Review of Current Therapy.

Spotlight on Mogamulizumab-Kpkc for Use in Adults with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome: Efficacy, Safety, and Patient Selection.

Condition: Relapsed or Refractory Mycosis Fungoides or Sezary Syndrome
Journal: Drug design, development and therapy
Treatment Used: Mogamulizumab-Kpkc
Number of Patients: 372
Published: September 28, 2020
View publication
Summary: Spotlight on Mogamulizumab-Kpkc for Use in Adults with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome: Efficacy, Safety, and Patient Selection.

Development of Sézary syndrome following the administration of dupilumab.

Condition: Atopic Dermatitis
Journal: Dermatology online journal
Treatment Used: Dupilumab
Number of Patients: 1
Published: July 05, 2020
View publication
Summary: Development of Sézary syndrome following the administration of dupilumab.

Combined total skin radiotherapy and immune checkpoint inhibitors: A promising potential treatment for mycosis fungoides and Sezary syndrome.

Condition: Mycosis Fungoides and Sezary Syndrome
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Treatment Used: Combined Total Skin Radiotherapy and Immune Checkpoint Inhibitors
Number of Patients: 0
Published: February 21, 2020
View publication
Summary: Combined total skin radiotherapy and immune checkpoint inhibitors: A promising potential treatment for mycosis fungoides and Sezary syndrome.

Outcome of allogeneic hematopoietic stem cell transplantation for mycosis fungoides and Sézary syndrome.

Condition: Mycosis Fungoides and Sézary Syndrome
Journal: Hematological oncology
Treatment Used: Allogeneic Hematopoietic Stem Cell Transplantation
Number of Patients: 18
Published: February 04, 2020
View publication
Summary: Outcome of allogeneic hematopoietic stem cell transplantation for mycosis fungoides and Sézary syndrome.

Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome.

Condition: Cutaneous Squamous Cell Carcinoma (cSCC) after Allogenic Hematopoietic Cell Transplant (allo-HCT)for Sézary Syndrome
Journal: Journal for immunotherapy of cancer
Treatment Used: Immune Checkpoint Inhibition
Number of Patients: 1
Published: December 06, 2019
View publication
Summary: Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome.

Mogamulizumab Forecast: Clearer Patients, with a Slight Chance of Immune Mayhem.

Condition: Cutaneous T-Cell Lymphoma
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Treatment Used: Mogamulizumab
Number of Patients: 0
Published: October 17, 2019
View publication
Summary: Mogamulizumab Forecast: Clearer Patients, with a Slight Chance of Immune Mayhem.
Showing 1-12 of 22

Last Updated : 05/19/2022